Chemotherapy-resistant intravascular lymphoma accompanied by ADAMTS13 inhibitor successfully treated with rituximab

Saved in:
Bibliographic Details
Published inInternational journal of hematology Vol. 88; no. 3; pp. 345 - 347
Main Authors Kanno, Masatoshi, Nakamura, Shinobu, Kawahara, Makoto, Ueno, Satoshi, Nakamine, Hirokazu, Matsumoto, Masanori, Fujimura, Yoshihiro
Format Journal Article
LanguageEnglish
Published Tokyo Springer Japan 01.10.2008
Springer Nature B.V
Subjects
ADAM Proteins - antagonists & inhibitors
ADAMTS13 Protein
Antibodies, Monoclonal - administration & dosage
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Agents - administration & dosage
Autoantibodies - blood
Drug Resistance, Neoplasm - drug effects
Enzyme Inhibitors - blood
Hematology
Humans
Letter to the Editor
Lymphoma, Large B-Cell, Diffuse - blood
Lymphoma, Large B-Cell, Diffuse - diagnosis
Lymphoma, Large B-Cell, Diffuse - drug therapy
Lymphoma, Large B-Cell, Diffuse - enzymology
Male
Medicine
Medicine & Public Health
Middle Aged
Oncology
Remission Induction
Rituximab
ADAMTS13 Activity
Autologous Peripheral Stem Cell Transplantation
Thrombotic Thrombocytopenic Purpura
ADAMTS13 Inhibitor
Autologous Peripheral Blood Stem Cell
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0925-5710
1865-3774
DOI:10.1007/s12185-008-0143-y